Rapid amelioration of muscle sympathetic nerve activity by pioglitazone in an obese Type 2 diabetic patient.
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology; D004594:Electrophysiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D008839:Microelectrodes; D008875:Middle Aged; D009132:Muscles / Q000294:innervation*; D009765:Obesity / Q000188:drug therapy* / Q000503:physiopathology; D000077205:Pioglitazone; D013564:Sympathetic Nervous System / Q000187:drug effects*; D045162:Thiazolidinediones / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone